Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC.
Nakazawa M, Fang M, Vong T, Zorzi J, Griffith P, Anders RA, Oshima K, Kim AK, Laurin J, Lafaro KJ, Shubert CR, Burns WR, He J, Burkhart RA, Philosophe B, Meyer J, Liddell RP, Georgiades C, Hong K, Ho WJ, Baretti M, Strauss AT, Yarchoan M. Nakazawa M, et al. Among authors: burns wr. Cancer Res Commun. 2024 Aug 1;4(8):2123-2132. doi: 10.1158/2767-9764.CRC-24-0151. Cancer Res Commun. 2024. PMID: 39142659 Free PMC article.
Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therapy and prognosis in pancreatic cancer.
Cui M, Shoucair S, Liao Q, Qiu X, Kinny-Köster B, Habib JR, Ghabi EM, Wang J, Shin EJ, Leng SX, Ali SZ, Thompson ED, Zimmerman JW, Shubert CR, Lafaro KJ, Burkhart RA, Burns WR, Zheng L, He J, Zhao Y, Wolfgang CL, Yu J. Cui M, et al. Among authors: burns wr. Int J Surg. 2023 Feb 1;109(2):99-106. doi: 10.1097/JS9.0000000000000200. Int J Surg. 2023. PMID: 36799816 Free PMC article.
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma.
Heumann T, Judkins C, Li K, Lim SJ, Hoare J, Parkinson R, Cao H, Zhang T, Gai J, Celiker B, Zhu Q, McPhaul T, Durham J, Purtell K, Klein R, Laheru D, De Jesus-Acosta A, Le DT, Narang A, Anders R, Burkhart R, Burns W, Soares K, Wolfgang C, Thompson E, Jaffee E, Wang H, He J, Zheng L. Heumann T, et al. Nat Commun. 2023 Jun 20;14(1):3650. doi: 10.1038/s41467-023-39196-9. Nat Commun. 2023. PMID: 37339979 Free PMC article.
Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center Analysis.
Gupta A, Zorzi J, Ho WJ, Baretti M, Azad NS, Griffith P, Dao D, Kim A, Philosophe B, Georgiades C, Kamel I, Burkhart R, Liddell R, Hong K, Shubert C, Lafaro K, Meyer J, Anders R, Burns W 3rd, Yarchoan M. Gupta A, et al. Healthcare (Basel). 2023 Sep 18;11(18):2571. doi: 10.3390/healthcare11182571. Healthcare (Basel). 2023. PMID: 37761768 Free PMC article.
Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal Adenocarcinoma.
Kinny-Köster B, Ahmad Y, Pflüger MJ, Habib JR, Fujikura K, Hutchings D, Cameron JL, Shubert CR, Lafaro KJ, Burkhart RA, Burns WR, Javed AA, Yu J, Hruban RH, Wood LD, Thompson ED, He J. Kinny-Köster B, et al. Among authors: burns wr. Pancreas. 2024 Jul 1;53(6):e528-e536. doi: 10.1097/MPA.0000000000002326. Pancreas. 2024. PMID: 38888841
Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma.
Nicolson NG, Tandurella JA, Wu LW, Patel J, Morris E, Seppälä TT, Guinn S, Zlomke H, Shubert CR, Lafaro KJ, Burns WR, Cameron JL, He J, Fertig EJ, Jaffee EM, Zimmerman JW, Burkhart RA. Nicolson NG, et al. Among authors: burns wr. Ann Surg. 2024 Sep 4. doi: 10.1097/SLA.0000000000006517. Online ahead of print. Ann Surg. 2024. PMID: 39229726
Poor Prognostic Factors in Long-Term Survivors of Resected Pancreatic Ductal Adenocarcinoma: An International, Multicenter Cohort Study.
Javed AA, Rompen IF, van Goor IWJM, Stoop TF, Andel P, Mahmud O, Fatimi AS, Habib JR, Mughal NA, Schouten T, Lafaro K, Burkhart RA, Burns WR, Santvoort HCV, Dulk MD, Daams F, Mieog JSD, Stommel MWJ, Patijn GA, Hingh I, Festen S, Nijkamp MW, Klaase JM, Lips DJ, Wijsman JH, Harst EV, Manusama E, Eijck CHJV, Koerkamp BG, Kazemier G, Busch OR, Molenaar IQ, Daamen LA, He J, Wolfgang CL, Besselink MG; Dutch Pancreatic Cancer Group and the PANC-PALS Consortium. Javed AA, et al. Among authors: burns wr. Ann Surg. 2024 Sep 17. doi: 10.1097/SLA.0000000000006539. Online ahead of print. Ann Surg. 2024. PMID: 39286904
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant Treatment.
Rompen IF, Sereni E, Habib JR, Garnier J, Galimberti V, Perez Rivera LR, Vatti D, Lafaro KJ, Hewitt DB, Sacks GD, Burns WR, Cohen S, Kaplan B, Burkhart RA, Turrini O, Wolfgang CL, He J, Javed AA. Rompen IF, et al. Among authors: burns wr. JCO Precis Oncol. 2024 Oct;8:e2400193. doi: 10.1200/PO.24.00193. Epub 2024 Nov 20. JCO Precis Oncol. 2024. PMID: 39565977
79 results